Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) is a diagnosis of exclusion making up the largest fraction (25--30%) of PTCL. Although traditionally considered a 'wastebasket\' diagnosis, recent gene-expression results suggest the disease comprises two biologic sub-entities characterized by expression of the transcription factors GATA3 or TBX21 and their target genes.^[@bib1]^ The mutational landscape of PTCL-NOS remains largely undefined.

We sought a better understanding the disease using a targeted deep-sequencing approach to identify pathogenic mechanisms and potential therapeutic targets that might fuel further studies. There is a substantial need for new therapies for PTCL-NOS, which leads to the death of more than two-thirds of patients within 5 years of diagnosis.^[@bib2]^ The median age of onset for PTCL-NOS is 60, two-thirds of patients are male, and 69% have advanced-stage at diagnosis. Front line treatment remains CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or other CHOP-based combinations optimized for use in B-cell lymphomas. Efforts to address the substantial unmet clinical need of PTCL-NOS patients are hampered by poor understanding of its biology, thwarting the development of specific therapies.

We collected 61 formalin-fixed paraffin embedded (FFPE) tumor samples from patients seen at Memorial Sloan-Kettering Cancer Center (MSKCC) with original diagnosis of PTCL-NOS, anaplastic large-cell lymphoma (ALCL) or angioimmunoblastic T-cell lymphoma (AITL). After re-review (JTF) of pathology and clinical factors, 31 cases met criteria for inclusion in this study of PTCL-NOS, lacking features indicative of other PTCL types. Pathologic details including morphology and immunophenotype are provided in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. In particular, we excluded cases with features of AITL because several studies have illuminated its mutational landscape,^[@bib3],\ [@bib4],\ [@bib5],\ [@bib6],\ [@bib7]^ while our interest was in PTCL-NOS, for which few disease-specific recurrent mutational targets have been reported. We chose 237 genes for deep sequencing that have been reported as recurrent mutational targets in other hematologic cancers ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}).

Analyzed tumor samples came from patients who consented to institutional tissue banking and analysis protocols, approved by the MSKCC Institutional Review Board and in compliance with the Declaration of Helsinki. Specific authorization for use and collection of de-identified clinical data came from the Human Biospecimen Use Committee. We isolated DNA from FFPE scrolls using the Formapure kit from Beckman Coulter Genomics in a semi-automated fashion on a Biomek NX liquid Handler. Illumina-compatible libraries were prepared from \~250 ng of sheared DNA (\~150 bp in size) on a Biomek SPRI-Works HT robot using the Kapa Biosystems High Throughput library preparation kit with SPRI solution (magnetic beads) and amplified using the Kapa Standard PCR Library Amplification/Illumina series. During library preparation, adapters with barcodes were added to the DNA fragments for sample identification. All exons of the 237 genes were captured using the Nimblegen system (Roche SeqCap EZ Custom bait hybridization probes). The samples were then pooled and run on an Illumina HiSeq sequencer.

Reads were aligned to the hg19 build of the human genome using BWA 0.6.2-r126 followed by duplicate removal using Picard-Tools-1.55. The Genome Analysis Toolkit (GATK-2.6--3-gdee51c4) was used to perform local realignment around known indels and base quality score recalibration. Variant detection was performed using the GATK Unified Genotyper. Quality settings in the GATK HaplotypeCaller resulted in the elimination of candidate variants at very low allele frequency, which while improving the overall confidence of reported mutations likely also excluded some tumor-specific sub-clonal variants. Variants were annotated with the SNPeff annotation program to identify protein-coding changes and cross-referenced against the dbSNP132, 1000 Genomes and Catalog of Somatic Mutations in Cancer (COSMIC) databases. We eliminated variants listed in dbSNP132 or 1000 genomes and reviewed all remaining variants manually in IGV 2.3 browser, resulting in the elimination of additional mutation calls based on sequencing quality, allele frequency (if similar to known single-nucleotide polymorphisms (SNPs) in the same sample) and by searching the internet to identify additional SNPs. Mean sequencing depth was 232X (range 6--701). Cases with mean sequencing depth \<100X (7 of 31) were included only if mutations were confirmed by targeting validation sequencing (see below), resulting in inclusion of four and exclusion of three such cases. This left 28 total cases for which we report mutations. Targeted validation sequencing of all mutations was performed with Illumina miSeq after re-amplification of DNA from the FFPE tumor samples, again using the Nimblegen capture system.

Of 28 patients, 25 with available demographic data were an average age of 52 years at diagnosis (range 9--76), with 11/25 age⩾60 and 13/25 male. Treatment and survival data were available for 23 patients followed long term at MSKCC. The majority of these (16) received CHOP or CHOP-like chemotherapy ([Supplementary Figure 1A](#sup1){ref-type="supplementary-material"}), whereas three received more intensive chemotherapy. Median event-free survival was 11.5 months, whereas median overall survival (OS) was 40.2 months ([Supplementary Figure 1B](#sup1){ref-type="supplementary-material"}). Subjects showed somewhat lower average age and less male predominance than is typical.^[@bib2]^ There was no OS difference between cases with nodal or extranodal presentation ([Supplementary Figure 1C](#sup1){ref-type="supplementary-material"}). Twenty-four of 28 samples were pretreatment and 4 were relapsed.

[Table 1](#tbl1){ref-type="table"} shows 89 protein-coding mutations found in the 28 cases, affecting 59 genes, including 74 single-nucleotide variants and 15 indels. There was a mean of 3.0 mutations per case (range 0--11). There was no significant difference between the mutational load in the four relapsed samples and others (*P*=0.283), but we can\'t exclude the possibility some mutations detected in these four samples were not present at diagnosis. Lack of germ-line DNA to confirm the somatic nature of mutations introduces the possibility that some mutations in [Table 1](#tbl1){ref-type="table"} are SNPs that are not reported in dbSNP132 or detected in the 1000 genomes project. We therefore limited further analysis to genes either recurrently mutated or containing mutations previously shown to be tumor specific in other studies. [Figure 1](#fig1){ref-type="fig"} shows breakdown of genes affected by such mutations by functional category and whether cases had a nodal or extranodal presentation.

As seen in other hematologic cancers, epigenetic regulation is the most mutated category overall. Regulators of histone methylation were mutated in 25% of cases, including *MLL2*^[@bib8]^ (4/28 cases), *KDM6A* (3/28) and *MLL* (2/28). Regulators of DNA methylation also were affected in 25% of cases. *TET2* showed previously reported frameshifts in two cases and a missense mutation in a third, whereas *DNMT3A* had a frameshift in one case and a previously reported missense mutation in a second. The significance of two previously unreported *TET1* missense mutations is less clear. There was no overlap between cases with histone methylation and DNA methylation alterations ([Supplementary Figure 2A](#sup1){ref-type="supplementary-material"}). Chromatin remodeling mediated by SWI/SNF complex activity is affected in 18%, specifically, *ARID1B* (3/28 cases), *ARID2* (1/28) and *SMARCA2* (1/28). These frequencies are similar to a recent meta-analysis of 44 cancer-sequencing studies.^[@bib9]^ Overall, epigenetic regulators emerge as recurrent targets of somatic mutations in PTCL-NOS.

Activation of T-cell receptor (TCR) signaling is a known pathogenic mechanism in PTCL-NOS containing t(5;9)(q33;q22), found in \<10 percent of cases.^[@bib10]^ The resulting ITK-SYK fusion kinase localizes to lipid-rafts and mimics constitutive TCR activation.^[@bib11]^ Our data highlight additional mechanisms activating TCR and downstream signaling. *TNFAIP3*, encoding the A20-negative regulator of NF-kB activation, had missense mutations in 11% (3/28) of cases, all of which are reported in the COSMIC. A20 is known to be a key regulator of NF-kB activation in T cells after TCR stimulation.^[@bib12]^ WNT/β-Catenin negative regulators *APC* and *CHD8* were affected in two cases each, or 14% (4/28) overall. Three additional genes with known suppressive roles in TCR activation had mutations previously reported in COSMIC: *NF1* (frameshift), *TNFRSF14* (missense affecting the start codon) and *TRAF3* (nonsense). Overall, 46% (13/28) had at least one mutation in TCR or downstream mediators, expanding the role for these processes in PTCL-NOS pathogenesis.

The *TP53* tumor suppressor gene had loss-of-function alterations in two cases, consistent with prior reports showing it is not mutated at a high rate in PTCL.^[@bib13],[@bib14]^ Additional affected suppressors include the *ATM* DNA-repair kinase (one case) and the transcription factors *FOXO1* and *BCORL1* (two cases each).

Examination of survival effects ([Supplementary Figure 2B](#sup1){ref-type="supplementary-material"}) showed cases with alterations in histone methylation (*MLL2*, *KDM6A*, or *MLL; P*=0.0198) had worse OS than unaffected cases, whereas there was no such effect for either DNA methylation (*TET2*, *DNMT3A*, or *TET1; P*=0.2694) or signaling (*TNFAIP3*, *APC*, *CHD8*, *ZAP70*, *NF1*, *TNFRSF14*, or *TRAF3; P*=0.6695). We also examined differences in mutational patterns between cases with nodal or extranodal presentation ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Although there was no significant difference in the above categories, interestingly all four cases affected by WNT/β-Catenin alterations were in the extranodal category (*P*=0.003).

Our study sheds new light on pathogenesis of a poorly understood clinical entity in need of better therapeutic options and for which poor sample availability has limited interrogation of the mutational landscape to date. Although some findings are confirmatory, others highlight novel disease mechanisms or better define frequency or prognostic implications. In particular, histone methylation alterations were present in a quarter of cases and associated with a worse OS. We believe studies in additional case series are warranted for elaboration of this result. Frequent mutations in regulators of TCR signaling meanwhile highlight mechanisms of activation, further extending the importance of this pathway beyond cases containing the previously identified ITK-SYK fusion kinase. The clustering of all mutations affecting WNT/β-Catenin mediators *APC* or *CHD8* in cases with an extranodal presentation represented a significant difference that should be explored in additional cases and could shed new light on extranodal PTCL-NOS. Therapeutic opportunities from some results are limited. Loss of function of A20, for example, does not easily lend itself to targeted treatment, as NF-kB Inducing Kinase inhibitors have not made their way to clinical evaluation. Low frequency of *TP53* mutations, however, highlights a potential for MDM2 inhibition in PTCL-NOS. In sum, we identify promising candidates for evaluation in additional cases and functional studies and to aid the development of better model systems for one of the least well understood hematologic malignancies.
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![Distribution of mutations in 28 diagnostic peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) cases. Included are all genes affected in multiple cases, or those affected in single cases with mutations listed in COSMIC or other reports as indicated in [Table 1](#tbl1){ref-type="table"}. Nodal: original presentation as nodal disease (black boxes) vs original extranodal presentation (white boxes).](leu2014261f1){#fig1}

###### Protein-affecting variants by gene and case

  *Gene*       *Case*     *CHR*  *POS*                 *REF*            *ALT*   *Mutant Allele Fraction*           *Type*              *Effect*      *Previous Report*
  ---------- ----------- ------- ------------- ---------------------- --------- -------------------------- ----------------------- ---------------- -------------------
  ALMS1          T06      chr2   73 676 742              T                A     0.39444                           Missense             p.S1029T            None
  ALPK2          T46      chr18  56 203 629              C                T     0.35000                           Missense             p.G1264S            None
  APC         99--31720   chr5   112 164 629             G                A     0.50131                           Missense             p.S568N            COSMIC
  APC            T52      chr5   112 176 308             G                A     0.42678                           Missense             p.E1673K           COSMIC
  ARID1B         T11      chr6   157 099 420             G             GCAGCAA  0.33333                        Codon insertion      p.119_120insQQ         None
  ARID1B         T33      chr6   157 431 662             G                A     0.42798                           Missense             p.A709T             None
  ARID1B         T56      chr6   157 528 066            CTG               C     0.44118                          Frameshift           p.C1932fs            None
  ARID2       99--31720   chr12  46 125 011              GA               G     0.28737                          Frameshift            p.N67fs            COSMIC
  ATM            T37      chr11  108 160 480             T                G     0.44118                           Missense             p.F1463C           COSMIC
  BCL6           T34      chr3   187 447 027             T                C     0.41648                           Missense             p.N389S             None
  BCL9           T55      chr1   147 095 762             C                T     0.41615                           Missense             p.P1095S            None
  BCORL1         T11      chrX   129 150 080             C                T     0.53977                           Missense             p.T1111M           COSMIC
  BCORL1         T46      chrX   129 147 806             C                T     0.47740                           Missense             p.P353L             None
  BRCA2          T39      chr13  32 906 921              A                G     0.40000                           Missense             p.K436E             None
  BRD4           T37      chr19  15 376 223              G                A     0.44444                           Missense             p.A264V             None
  BRIP1          T81      chr17  59 885 858              C                G     0.42308                           Missense             p.E296D             None
  CD58           T39      chr1   117 061 887             T                C     0.85185                           Missense             p.I237V             None
  CDH23          T34      chr10  73 501 454              G                A     0.40785                           Missense             p.V1541M            None
  CHD8           T46      chr14  21 894 360              G                T     0.46903                           Missense             p.T269N             None
  CHD8           T55      chr14  21 859 651              C                T     0.48592                           Missense             p.E2067K            None
  CIITA          T55      chr16  11 004 047              C                T     0.44654                           Missense             p.T940M             None
  CIITA          T56      chr16  11 000 940              G                A     0.43501                           Missense             p.G531S             None
  CMYA5          T33      chr5   79 034 658              G                C     0.36957                           Missense             p.S3357T            None
  COL6A3         T39      chr2   238 296 329             G                A     0.42345                           Missense             p.P403L            COSMIC
  COL6A3         T55      chr2   238 277 596             G                A     0.38728                           Missense             p.R1504W           COSMIC
  CREBBP         T33      chr16  3 824 628               C                G     0.40741                           Missense             p.R704P             None
  CREBBP         T52      chr16  3 778 708               C                T     0.42241                           Missense             p.G2076S            None
  CUL9           T34      chr6   43 154 017              C                G     0.51064                           Missense             p.Q359E         Ref. [@bib15]
  DDX3X          T46      chrX   41 204 494              A                T     0.48918                           Nonsense             p.R363\*            None
  DNMT3A         T09      chr2   25 463 248              G                A     0.30313                           Missense             p.R749C            COSMIC
  DNMT3A         T26      chr2   25 467 432             CAT               C     0.19303                          Frameshift            p.M548fs            None
  FBXW7          T39      chr4   153 332 910             C              CAGG    0.42920                        Codon insertion       p.15_16insP          COSMIC
  FBXW7          T81      chr4   153 268 155             TG               T     0.17647                          Frameshift            p.Q100fs           COSMIC
  FOXO1       99--31720   chr13  41 240 039              C                G     0.31250                           Missense             p.G104A             None
  FOXO1          T46      chr13  41 240 273              G                A     0.25547                           Missense              p.P26L             None
  FYB            T59      chr5   39 202 971              C                A     0.37037                           Missense              p.G31V             None
  IDH2           T06      chr15  90 645 600              A                G     0.41176                           Missense              p.V8A              None
  IL7R           T39      chr5   35 876 541              C                T     0.45918                           Nonsense             p.Q445\*            None
  IRF4           T39      chr6   394 888                 C                G     0.37700                           Missense              p.T95R             None
  IRF8           T39      chr16  85 936 739              T                A     0.38928                           Missense              p.W40R             None
  JAK3           T52      chr19  17 937 710              G                A     0.44845                           Missense             p.L1073F            None
  KDM4C          T46      chr9   7 046 915               T                A     0.30758                           Missense             p.N771K             None
  KDM6A       99--31720   chrX   44 941 837              G               GT     0.54369                          Frameshift           p.R1054fs            None
  KDM6A          T46      chrX   44 733 220              C                T     0.42655                           Missense              p.A71V             None
  KDM6A          T56      chrX   44 913 193              C               CT     0.41379                          Frameshift            p.G291fs            None
  KIAA1618       T52      chr17  78 264 463             AGAG              A     0.42010                        Codon deletion         p.G404del            None
  LRRK1          T34      chr15  101 514 110             C                T     0.36364                           Missense              p.R67C             None
  LRRK1          T34      chr15  101 549 251             C                G     0.34553                           Missense             p.D324E             None
  LRRK1          T59      chr15  101 567 909             G                A     0.41379                           Missense             p.D865N             None
  MLL            T33      chr11  118 366 578             C                T     0.32051                           Missense             p.P1840S            None
  MLL            T46      chr11  118 373 835             A                G     0.43956                           Missense             p.M2407V            None
  MLL2        99--31720   chr12  49 434 709              G                A     0.51190                           Missense             p.R2282W            None
  MLL2           T08      chr12  49 445 392              G                T     0.51471                           Missense             p.P692T         Ref. [@bib8]
  MLL2           T73      chr12  49 433 883              G                A     0.44056                           Missense             p.P2557L            None
  MLL2           T81      chr12  49 448 530              C                G     0.32143                           Missense              p.G61R             None
  MPDZ           T39      chr9   13 192 237              C                A     0.67901                           Nonsense             p.E621\*            None
  NF1            T69      chr17  29 553 477              A               AC     0.30303                          Frameshift            p.P678fs           COSMIC
  PASD1          T34      chrX   150 844 560             C                T     0.39912                           Missense             p.A756V             None
  PASK           T06      chr2   242 080 117             C                T     0.41535                           Missense              p.C83Y             None
  PCLO           T04      chr7   82 763 889              T                A     0.31897                           Missense             p.S993C             None
  PCLO           T39      chr7   82 546 098              C                T     0.41736                           Missense             p.G3735E            None
  PCLO           T39      chr7   82 583 972              G                T     0.40136                           Missense             p.D2099E            None
  PCLO           T46      chr7   82 595 148              T                G     0.25290                           Missense             p.E1319A            None
  PHLPP          T04      chr18  60 645 819              G                A     0.47619                           Missense             p.G925S             None
  PLCG2          T55      chr16  81 902 872              G                A     0.48000                           Missense             p.S178N             None
  RELN           T37      chr7   103 136 199             T                C     0.48413                           Missense             p.I3114V            None
  SAMD9          T55      chr7   92 731 734              C                A     0.38095                           Missense             p.R1226I            None
  SETBP1         T38      chr18  42 456 670              C              CTCTT   0.19608                          Frameshift            p.T228fs            None
  SETBP1         T56      chr18  42 456 691              A                C     0.25641                           Missense             p.E234D             None
  SMARCA2        T73      chr9   2 039 844               A                T     0.41176                           Missense             p.Q245L             None
  STAT5B         T81      chr17  40 375 521              C                G     0.38710                           Missense             p.Q143H             None
  TET1           T34      chr10  70 333 197              G                C     0.42177                           Missense             p.A368P             None
  TET1           T58      chr10  70 426 857              C                T     0.38255                           Missense             p.T1506I            None
  TET2           T31      chr4   106 193 809             CT               C     0.36364                          Frameshift           p.S1424fs           COSMIC
  TET2           T65      chr4   106 157 694         GCAATATTT            G     0.30000                          Frameshift            p.Q866fs           COSMIC
  TET2           T69      chr4   106 164 733             C                T     0.28571                           Missense             p.R1201C            None
  TNFAIP3        T02      chr6   138 195 991             A                G     0.39706                           Missense             p.N102S            COSMIC
  TNFAIP3        T37      chr6   138 201 240             A                C     0.48916                           Missense             p.T647P            COSMIC
  TNFAIP3        T73      chr6   138 201 240             A                C     0.37647                           Missense             p.T647P            COSMIC
  TNFRSF14       T61      chr1   2 488 104               A                G     0.16413                     Missense; Start codon       p.M1V             COSMIC
  TP53           T04      chr17  7 579 492      TCTGGGAGCTTCATCTGGAC      T     0.31169                          Frameshift            p.G59fs            COSMIC
  TP53           T56      chr17  7 578 190               T                C     0.86620                           Missense             p.Y220C            COSMIC
  TRAF3          T73      chr14  103 363 658             C                T     0.52830                           Nonsense             p.Q294\*           COSMIC
  ULK4           T81      chr3   41 860 984              C               CT     0.21053                          Frameshift            p.N594fs            None
  ZAP70          T38      chr2   98 351 166              G                C     0.21287                           Missense             p.R358P             None
  ZAP70          T39      chr2   98 354 531              C                T     0.36923                           Missense             p.P566L             None
  ZFHX3          T34      chr16  72 831 834              C                A     0.37500                           Missense             p.G1583C            None
  ZMYM3          T38      chrX   70 469 934              G                C     0.33333                           Missense             p.P398R             None
  ZNF608         T46      chr5   123 985 372             A                G     0.39334                           Missense             p.V394A             None
